Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study.

Source:http://linkedlifedata.com/resource/pubmed/id/15714201

Br. J. Cancer 2005 Mar 14 92 5 815-9

Download in:

View as

Triples

General Info

PMID
15714201